Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

8.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

9.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

9.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
T Cell Types and Functions01:24

T Cell Types and Functions

3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foxp1 controls Fezf2-dependent gene expression, mimetic mTEC diversity, and thymic central tolerance.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Thymic alveolar type 2 epithelial mimetic cells revealed by RUNX1 deficiency.

Nature immunology·2026
Same author

Dissecting ARL15 Function in Rheumatoid Arthritis: Insights From Ex Vivo and in Vitro Synovial Fibroblast Models.

International journal of rheumatic diseases·2026
Same author

IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.

Cancer research·2026
Same author

A machine learning classifier to identify and prioritise genes associated with murine cardiac development.

PLoS genetics·2026
Same author

Correlates of HIV-1 control after combination immunotherapy.

Nature·2025

Related Experiment Video

Updated: Apr 14, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K

ATF7ip Inhibits the Tumor Immune Response by Promoting Terminal CD8+ T-cell Exhaustion.

Sujit Kashyap1, Jun Hyung Sin1,2, Sophia M Guldberg2

  • 1Department of Pediatrics, University of California San Francisco, San Francisco, California.

Cancer Immunology Research
|April 13, 2026
PubMed
Summary

Activating transcription factor 7 interacting protein (ATF7ip) drives CD8+ T cell exhaustion, limiting anti-tumor immunity. Inhibiting ATF7ip reduces exhaustion, enhancing T cell function for improved cancer immunotherapy.

More Related Videos

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

1.3K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.6K

Related Experiment Videos

Last Updated: Apr 14, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

1.3K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.6K

Area of Science:

  • Immunology
  • Epigenetics
  • Cancer Biology

Background:

  • CD8+ T cell exhaustion impairs anti-tumor immune responses.
  • Epigenetic regulators are increasingly recognized for their role in T cell exhaustion.
  • Targeting T cell exhaustion is crucial for effective cancer therapies.

Purpose of the Study:

  • To identify novel epigenetic regulators of CD8+ T cell exhaustion.
  • To investigate the role of Activating Transcription Factor 7 Interacting Protein (ATF7ip) in T cell exhaustion.
  • To explore ATF7ip as a potential therapeutic target for enhancing anti-tumor immunity.

Main Methods:

  • Genetic deletion of Atf7ip in CD8+ T cells.
  • Analysis of T cell exhaustion markers in chronic viral infection and cancer models.
  • Chromatin immunoprecipitation to assess H3K9me3 deposition at immune-effector gene loci.

Main Results:

  • Loss of Atf7ip reduced terminal CD8+ T cell exhaustion and increased progenitor-exhausted cells.
  • Atf7ip deficiency led to decreased tumor burden in cancer models.
  • ATF7ip promotes H3K9me3 deposition at key immune-effector genes (e.g., Il7r, Il2), enhancing exhaustion.

Conclusions:

  • ATF7ip is a critical epigenetic driver of CD8+ T cell exhaustion.
  • Targeting ATF7ip can restore T cell effector function and reduce tumor burden.
  • ATF7ip is a promising target for adoptive T cell therapies to overcome cancer immune evasion.